Long-term outcomes after hepatitis C virus eradication: a message for clinicians

Minerva Med. 2019 Dec;110(6):487-489. doi: 10.23736/S0026-4806.19.06211-6. Epub 2019 Jul 5.

Author

Elena Gentilcore¹

Affiliation

¹ Unit of Gastroenterology, Centre Hospitalier des Escartons, Briançon, France - egentilcore@ch-briancon.fr.

PMID: 31282139
DOI: 10.23736/S0026-4806.19.06211-6

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / etiology
Dyslipidemias / epidemiology
Dyslipidemias / etiology
Fatty Liver / epidemiology
Fatty Liver / etiology
Glucose Intolerance / epidemiology
Glucose Intolerance / etiology
Hepatitis C / complications
Hepatitis C / drug therapy*
Hepatitis C / mortality
Humans
Interferons / therapeutic use
Prognosis
Remission Induction
Retrospective Studies
Survival Rate
Treatment Outcome

Substances

Antiviral Agents
Interferons